Our data shows that the majority of CRC patients had acquired CNV or mutations to m6A modification genes, with 76%, 64%, and 58% cases harboring YTHDF1, ZC3H13, and VIRMA CNV, respectively. The gene discussed is YTHDF1; the disease is colorectal carcinoma.